BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38738555)

  • 1. METTL14 decreases FTH1 mRNA stability via m6A methylation to promote sorafenib-induced ferroptosis of cervical cancer.
    Li L; Zeng J; He S; Yang Y; Wang C
    Cancer Biol Ther; 2024 Dec; 25(1):2349429. PubMed ID: 38738555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. piRNA-14633 promotes cervical cancer cell malignancy in a METTL14-dependent m6A RNA methylation manner.
    Xie Q; Li Z; Luo X; Wang D; Zhou Y; Zhao J; Gao S; Yang Y; Fu W; Kong L; Sun T
    J Transl Med; 2022 Jan; 20(1):51. PubMed ID: 35093098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cdc25A inhibits autophagy-mediated ferroptosis by upregulating ErbB2 through PKM2 dephosphorylation in cervical cancer cells.
    Wang C; Zeng J; Li LJ; Xue M; He SL
    Cell Death Dis; 2021 Nov; 12(11):1055. PubMed ID: 34743185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
    Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
    Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHOP regulated by METTL14-m6A affects cell cycle arrest and regorafenib sensitivity in HCC cells.
    Pan Y; You B; Zhao X; Zhang S; Li W
    BMC Cancer; 2024 Apr; 24(1):525. PubMed ID: 38664644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIM11 regulated by m6A modification promotes the progression of cervical cancer by PHLPP1 ubiquitination.
    Zhang P; Tang Y; Zhao J; Yang J; Chen Y; Gong Y; Meng S; Shu C
    Neoplasma; 2023 Oct; 70(5):659-669. PubMed ID: 38053376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of METTL14 mediates the elevation of PERP mRNA N
    Wang M; Liu J; Zhao Y; He R; Xu X; Guo X; Li X; Xu S; Miao J; Guo J; Zhang H; Gong J; Zhu F; Tian R; Shi C; Peng F; Feng Y; Yu S; Xie Y; Jiang J; Li M; Wei W; He C; Qin R
    Mol Cancer; 2020 Aug; 19(1):130. PubMed ID: 32843065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. METTL14-mediated N
    Liu Z; Sun T; Piao C; Zhang Z; Kong C
    Cell Commun Signal; 2022 Mar; 20(1):36. PubMed ID: 35305660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST.
    Yang X; Zhang S; He C; Xue P; Zhang L; He Z; Zang L; Feng B; Sun J; Zheng M
    Mol Cancer; 2020 Feb; 19(1):46. PubMed ID: 32111213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. M6A-induced transcription factor IRF5 contributes to the progression of cervical cancer by upregulating PPP6C.
    Hou PX; Fan Q; Zhang Q; Liu JJ; Wu Q
    Clin Exp Pharmacol Physiol; 2024 Jul; 51(7):e13868. PubMed ID: 38745265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia blocks ferroptosis of hepatocellular carcinoma via suppression of METTL14 triggered YTHDF2-dependent silencing of SLC7A11.
    Fan Z; Yang G; Zhang W; Liu Q; Liu G; Liu P; Xu L; Wang J; Yan Z; Han H; Liu R; Shu M
    J Cell Mol Med; 2021 Nov; 25(21):10197-10212. PubMed ID: 34609072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma.
    Liu L; He J; Sun G; Huang N; Bian Z; Xu C; Zhang Y; Cui Z; Xu W; Sun F; Zhuang C; Man Q; Gu S
    Clin Transl Med; 2022 May; 12(5):e778. PubMed ID: 35522946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA CACNA1G-AS1 up-regulates FTH1 to inhibit ferroptosis and promote malignant phenotypes in ovarian cancer cells.
    Jin Y; Qiu J; Lu X; Ma Y; Li G
    Oncol Res; 2023; 31(2):169-179. PubMed ID: 37304234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. METTL14 promotes the migration and invasion of breast cancer cells by modulating N6‑methyladenosine and hsa‑miR‑146a‑5p expression.
    Yi D; Wang R; Shi X; Xu L; Yilihamu Y; Sang J
    Oncol Rep; 2020 May; 43(5):1375-1386. PubMed ID: 32323801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
    Ma Z; Li Q; Liu P; Dong W; Zuo Y
    Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV E6/E7 promotes aerobic glycolysis in cervical cancer by regulating IGF2BP2 to stabilize m
    Hu C; Liu T; Han C; Xuan Y; Jiang D; Sun Y; Zhang X; Zhang W; Xu Y; Liu Y; Pan J; Wang J; Fan J; Che Y; Huang Y; Zhang J; Ding J; Yang S; Yang K
    Int J Biol Sci; 2022; 18(2):507-521. PubMed ID: 35002506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin attenuates multiple myeloma cell proliferation and encourages apoptosis by suppressing METTL3-mediated m6A methylation of THRAP3, RBM25, and USP4.
    Chen CJ; Huang JY; Huang JQ; Deng JY; Shangguan XH; Chen AZ; Chen LT; Wu WH
    Cell Cycle; 2023 Apr; 22(8):986-1004. PubMed ID: 36762777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The m6A methyltransferase METTL14 inhibits the proliferation, migration, and invasion of gastric cancer by regulating the PI3K/AKT/mTOR signaling pathway.
    Liu X; Xiao M; Zhang L; Li L; Zhu G; Shen E; Lv M; Lu X; Sun Z
    J Clin Lab Anal; 2021 Mar; 35(3):e23655. PubMed ID: 33314339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. METTL14-Mediated miR-30c-1-3p Maturation Represses the Progression of Lung Cancer via Regulation of MARCKSL1 Expression.
    Li F; Zhao J; Wang L; Chi Y; Huang X; Liu W
    Mol Biotechnol; 2022 Feb; 64(2):199-212. PubMed ID: 34586620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NSUN5-FTH1 Axis Inhibits Ferroptosis to Promote the Growth of Gastric Cancer Cells.
    Su Y; Liu J; Zheng Z; Shi L; Huang W; Huang X; Ye C; Qi J; Wang W; Zhuang H
    Cell Biochem Biophys; 2023 Sep; 81(3):553-560. PubMed ID: 37528314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.